advaxis inc
Biocon, Advaxis To Develop Cancer Immunotherapy Against HPV
Biocon and Advaxis will co-develop and commercialize ADXS-HPV, a novel cancer immunotherapy for the treatment of HPV.
Biocon and Advaxis will co-develop and commercialize ADXS-HPV, a novel cancer immunotherapy for the treatment of HPV.